Companies / Sunshine Biopharma Inc.

Sunshine Biopharma Inc.

Nasdaq: SBFMCIK 1402328FORT LAUDERDALE, FL

Financials · FY2025

Revenue$36.31M
Net income$-5.98M
Total debt$2.05M
Cash$19.73M
Diluted EPS$-7.32
Shares outstanding5.0M

Ownership

5.0M shares outstanding · as of May 13, 2026
2.0%Insiders
Ownership
Insiders2.00%100,000
Institutions2.30%114,999
Public float95.71%4,790,946

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
Natan DavidDirector
2.00%100,000

Institutional holders 13

View all →
HolderValue% of shares
Citadel Advisors LLC$66.3K1.08%
XTX Topco Ltd$19.9K0.32%
Morgan Stanley$18.0K0.29%
SBI Securities Co., Ltd.$6.0K0.10%
UBS Group AG$2.3K0.04%
Osaic Holdings, Inc.$186<0.01%
Virtu Financial LLC$290.47%
National Bank of Canada /Fi$12<0.01%
Bank of America Corp /De$6<0.01%
SageView Advisory Group, LLC$2<0.01%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Apr 14, 2026Natan David
Director
GrantCommon Stock$0+100K
100,000
2.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Bigger Capital Fund L PPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SBFM——867781700—